ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation ; volume:14 ; number:1 ; day:25 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (25.11.2024), 1-13, 12.2024
- Urheber
-
Wang, Jinming
Li, Quanwei
Huo, Yunfei
Liu, Xiaoni
Shi, Ying
Xie, Bangxiang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-80415-0
- URN
-
urn:nbn:de:101:1-2502102123034.705662494581
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wang, Jinming
- Li, Quanwei
- Huo, Yunfei
- Liu, Xiaoni
- Shi, Ying
- Xie, Bangxiang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis
Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms
WWOX promotes osteosarcoma development via upregulation of Myc
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration
TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction
Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
TET2 deficiency promotes MDS-associated leukemogenesis
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis
Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms
WWOX promotes osteosarcoma development via upregulation of Myc
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration
TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction
Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
TET2 deficiency promotes MDS-associated leukemogenesis
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis
Interleukin-21 receptor signaling promotes metabolic dysfunction-associated steatohepatitis-driven hepatocellular carcinoma by inducing immunosuppressive IgA+ B cells
Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms
WWOX promotes osteosarcoma development via upregulation of Myc
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
NDRG1 upregulation by ubiquitin proteasome system dysfunction aggravates neurodegeneration
TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction
Sphingosine d18:1 promotes nonalcoholic steatohepatitis by inhibiting macrophage HIF-2α
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)